Successful outpatient management of pelvic actinomycosis by ceftriaxone: a report of three cases

Abstract

Pelvic actinomycosis is a chronic granulomatous suppurative disease caused by actinomyces israeli. Intravenous penicillin is the preferred antimicrobial but it requires hospitalization up to one month. An outpatient treatment strategy would be cost effective and a good choice for patients. Here we present three cases in which intramuscular ceftriaxone was successfully used in the outpatient settings following surgery and IV penicillin treatment in the hospital.

Keywords

• Ceftriaxone
• actinomycosis
• penicillins
• pelvic neoplasms
• intrauterine devices